Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients

Trial Profile

Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Fimasartan (Primary)
  • Indications Diastolic heart failure
  • Focus Therapeutic Use
  • Acronyms FINE
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 29 Dec 2015 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 22 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Aug 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top